{"id":"NCT01816295","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Parallel Study With an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05","primaryCompletion":"2014-10","completion":"2015-04","firstPosted":"2013-03-22","resultsPosted":"2015-10-02","lastUpdate":"2015-12-28"},"enrollment":715,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypogonadism"],"interventions":[{"type":"DRUG","name":"Testosterone Solution","otherNames":["Axiron","Testosterone Solution 2%","LY900011"]},{"type":"DRUG","name":"Placebo Solution","otherNames":[]}],"arms":[{"label":"Placebo Solution","type":"PLACEBO_COMPARATOR"},{"label":"Testosterone Solution","type":"EXPERIMENTAL"}],"summary":"The main purpose of this study is to evaluate if testosterone solution can raise testosterone hormone levels into the normal range, and also improve levels of sexual arousal, interest and drive and/or energy level, in men with low testosterone and decreased sexual arousal, interest and drive and/or decreased energy. The study will last about 16 weeks, followed by an optional 24 week open label treatment phase to investigate the long term safety of testosterone solution.","primaryOutcome":{"measure":"Number of Participants With Total Serum Testosterone Concentration Within Normal Range at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo Solution","deltaMin":43,"sd":null},{"arm":"Testosterone Solution","deltaMin":217,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":34},"locations":{"siteCount":85,"countries":["United States","Argentina","Canada","Germany","Italy","Puerto Rico","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["38224135","26498057"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":356},"commonTop":["Haematocrit increased","Nasopharyngitis","Upper respiratory tract infection","Back pain","Arthralgia"]}}